Chronic Optogenetic Activation Augments Aβ Pathology in a Mouse Model of Alzheimer Disease
Cell Reports, ISSN: 2211-1247, Vol: 11, Issue: 6, Page: 859-865
2015
- 190Citations
- 266Usage
- 383Captures
- 2Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations190
- Citation Indexes190
- 190
- CrossRef135
- Usage266
- Downloads245
- Abstract Views21
- Captures383
- Readers383
- 383
- Mentions2
- News Mentions2
- News2
Most Recent News
Chronic optogenetic activation augments aβ pathology in a mouse model of Alzheimer disease.
Authors: Kaoru Yamamoto, Zen-Ichi Tanei, Tadafumi Hashimoto, Tomoko Wakabayashi, Hiroyuki Okuno, Yasushi Naka, Ofer Yizhar, Lief E Fenno, Masashi Fukayama, Haruhiko Bito, John R Cirrito,
Article Description
In vivo experimental evidence indicates that acute neuronal activation increases Aβ release from presynaptic terminals, whereas long-term effects of chronic synaptic activation on Aβ pathology remain unclear. To address this issue, we adopted optogenetics and transduced stabilized step-function opsin, a channelrhodopsin engineered to elicit a long-lasting neuronal hyperexcitability, into the hippocampal perforant pathway of APP transgenic mice. In vivo microdialysis revealed a ∼24% increase in the hippocampal interstitial fluid Aβ42 levels immediately after acute light activation. Five months of chronic optogenetic stimulation increased Aβ burden specifically in the projection area of the perforant pathway (i.e., outer molecular layer of the dentate gyrus) of the stimulated side by ∼2.5-fold compared with that in the contralateral side. Epileptic seizures were observed during the course of chronic stimulation, which might have partly contributed to the Aβ pathology. These findings implicate functional abnormalities of specific neuronal circuitry in Aβ pathology and Alzheimer disease.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211124715004040; http://dx.doi.org/10.1016/j.celrep.2015.04.017; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84929279549&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/25937280; https://linkinghub.elsevier.com/retrieve/pii/S2211124715004040; https://digitalcommons.wustl.edu/open_access_pubs/3844; https://digitalcommons.wustl.edu/cgi/viewcontent.cgi?article=4848&context=open_access_pubs; http://linkinghub.elsevier.com/retrieve/pii/S2211124715004040
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know